In the non-diabetic setting, a comparable body of literature has reported potential anti-fibrotic renal effects of HDAC inhibition and HDAC inhibitors have also been reported to offer other metabolic benefits in diabetes. The gene discussed is HDAC9; the disease is diabetes mellitus.